Search Results - "SIEGMUND, W."

Refine Results
  1. 1

    Impact of Bariatric Surgery on Drug Transport And Metabolism by Siegmund, W

    Published in Clinical therapeutics (01-08-2015)
    “…[...]the changes are complex and poorly understood, and long-lasting mucosal adaptation of intestinal functions may occur. [...]potential transcriptional and…”
    Get full text
    Journal Article
  2. 2

    Intragastric pH and pressure profiles after intake of the high-caloric, high-fat meal as used for food effect studies by Koziolek, M., Schneider, F., Grimm, M., Modeβ, Chr, Seekamp, A., Roustom, T., Siegmund, W., Weitschies, W.

    Published in Journal of controlled release (28-12-2015)
    “…The intraluminal conditions of the fed stomach are critical for drug release from solid oral dosage forms and thus, often associated with the occurrence of…”
    Get full text
    Journal Article
  3. 3

    LC–MS/MS-based quantification of clinically relevant intestinal uptake and efflux transporter proteins by Gröer, C., Brück, S., Lai, Y., Paulick, A., Busemann, A., Heidecke, C.D., Siegmund, W., Oswald, S.

    “…•LC–MS/MS methods for ten drug transporters (ABCB1, ABCC2, ABCC3, ABCG2, OATP1A2, OATP2B1, PEPT1, ASBT, OCT1 and OCT3).•First quantitative assays for ABCC3,…”
    Get full text
    Journal Article
  4. 4

    Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics by Gröer, C., Busch, D., Patrzyk, M., Beyer, K., Busemann, A., Heidecke, C.D., Drozdzik, M., Siegmund, W., Oswald, S.

    “…•Simultaneous LC–MS/MS-based quantification of 13 relevant metabolizing enzymes.•Comprehensive method validation for all aforementioned enzymes.•Application to…”
    Get full text
    Journal Article
  5. 5

    Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging by SCHILLER, C., FRÖHLICH, C.‐P., GIESSMANN, T., SIEGMUND, W., MÖNNIKES, H., HOSTEN, N., WEITSCHIES, W.

    Published in Alimentary pharmacology & therapeutics (01-11-2005)
    “…Summary Aim : The gastrointestinal transit of sequentially administered capsules was investigated in relation to the availability of fluid along the intestinal…”
    Get full text
    Journal Article
  6. 6

    The Far Ultra-Violet Imager on the Icon Mission by Mende, S. B., Frey, H. U., Rider, K., Chou, C., Harris, S. E., Siegmund, O. H. W., England, S. L., Wilkins, C., Craig, W., Immel, T. J., Turin, P., Darling, N., Loicq, J., Blain, P., Syrstad, E., Thompson, B., Burt, R., Champagne, J., Sevilla, P., Ellis, S.

    Published in Space science reviews (01-10-2017)
    “…ICON Far UltraViolet (FUV) imager contributes to the ICON science objectives by providing remote sensing measurements of the daytime and nighttime…”
    Get full text
    Journal Article Web Resource
  7. 7

    Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function by Laechelt, S, Turrini, E, Ruehmkorf, A, Siegmund, W, Cascorbi, I, Haenisch, S

    Published in The pharmacogenomics journal (01-02-2011)
    “…ABCC2 (MRP2) is an important export pump, expressed at tissue barriers. The genetic variants −24C>T, 1249G>A and 3972C>T are leading to inter-individual…”
    Get full text
    Journal Article
  8. 8

    ALICE: The Ultraviolet Imaging Spectrograph Aboard the New Horizons Pluto–Kuiper Belt Mission by Stern, S. Alan, Slater, David C., Scherrer, John, Stone, John, Dirks, Greg, Versteeg, Maarten, Davis, Michael, Gladstone, G. Randall, Parker, Joel W., Young, Leslie A., Siegmund, Oswald H. W.

    Published in Space science reviews (01-10-2008)
    “…The ALICE instrument is a lightweight (4.4 kg), low-power (4.4 watt) imaging spectrograph aboard the New Horizons mission to the Pluto system and the Kuiper…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Preventable ADRs leading to hospitalization - results of a long-term prospective safety study with 6,427 ADR cases focusing on elderly patients by Schmiedl, S, Rottenkolber, M, Szymanski, J, Drewelow, B, Siegmund, W, Hippius, M, Farker, K, Guenther, I R, Hasford, J, Thuermann, P A

    Published in Expert opinion on drug safety (01-02-2018)
    “…Studies evaluating the impact of age and potentially inappropriate medication (PIM) on avoidable adverse drug reactions (ADRs) are scarce. In this prospective,…”
    Get more information
    Journal Article
  12. 12

    Pharmacokinetics and pulmonary distribution of gamithromycin after intravenous administration in foals by Berlin, S., Randow, T., Scheuch, E., Grube, M., Venner, M., Siegmund, W.

    “…The long‐acting azalide antibiotic gamithromycin is marketed for intramuscular treatment of bovine and swine infections. Off‐label use in foals leads to severe…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Pharmacological indices and pulmonary distribution of rifampicin after repeated oral administration in healthy foals by Berlin, S., Kirschbaum, A., Spieckermann, L., Oswald, S., Keiser, M., Grube, M., Venner, M., Siegmund, W.

    Published in Equine veterinary journal (01-09-2017)
    “…Summary Background The treatment of equine lung infections by Rhodococcus equi with rifampicin is empirically based because pharmacokinetic/pharmacodynamic…”
    Get full text
    Journal Article
  15. 15

    Intestinal and hepatic contributions to the pharmacokinetic interaction between gamithromycin and rifampicin after single‐dose and multiple‐dose administration in healthy foals by Berlin, S., Wallstabe, S., Scheuch, E., Oswald, S., Hasan, M., Wegner, D., Grube, M., Venner, M., Ullrich, A., Siegmund, W.

    Published in Equine veterinary journal (01-07-2018)
    “…Summary Background Standard treatment of foals with severe abscessing lung infection caused by Rhodococcus equi using rifampicin and a macrolide antibiotic can…”
    Get full text
    Journal Article
  16. 16

    Dose-Dependent Pharmacokinetics and Metabolisms of Prolonged-Release Ketamine Tablets in Healthy Subjects by Hasan, M, Modess, C, Roustom, T, Wegner, D, Oswald, S, Rey, H, Zimmer, M, Siegmund, W

    Published in Clinical therapeutics (01-08-2017)
    “…There is ample new evidence, firstly, that metabolites of NK, as the 2R,6R/2S,6S-enantiomers of hydroxynorketamin (HNK), exert neuro-modulating effects by…”
    Get full text
    Journal Article
  17. 17

    Perfusion of human placenta with hemoglobin introduces preeclampsia-like injuries that are prevented by α1 -microglobulin by May, K, Rosenlöf, L, Olsson, M.G, Centlow, M, Mörgelin, M, Larsson, I, Cederlund, M, Rutardottir, S, Siegmund, W, Schneider, H, Åkerström, B, Hansson, S.R

    Published in Placenta (Eastbourne) (01-04-2011)
    “…Abstract Background Preeclamptic women have increased plasma levels of free fetal hemoglobin (HbF), increased gene expression of placental HbF and accumulation…”
    Get full text
    Journal Article
  18. 18

    High Resolution Neutron Resonance Absorption Imaging at a Pulsed Neutron Beamline by Tremsin, A. S., McPhate, J. B., Vallerga, J. V., Siegmund, O. H. W., Kockelmann, W., Schooneveld, E. M., Rhodes, N. J., Feller, W. B.

    Published in IEEE transactions on nuclear science (01-12-2012)
    “…The existence of resonance peaks in neutron absorption spectra in the epithermal range of energies enables unique non-destructive testing techniques. The deep…”
    Get full text
    Journal Article
  19. 19

    Imaging of dynamic magnetic fields with spin-polarized neutron beams by Tremsin, A S, Kardjilov, N, Strobl, M, Manke, I, Dawson, M, McPhate, J B, Vallerga, J V, Siegmund, O H W, Feller, W B

    Published in New journal of physics (22-04-2015)
    “…Precession of neutron spin in a magnetic field can be used for mapping of a magnetic field distribution, as demonstrated previously for static magnetic fields…”
    Get full text
    Journal Article
  20. 20

    Impact of Efavirenz on Intestinal Metabolism and Transport: Insights From an Interaction Study With Ezetimibe in Healthy Volunteers by Oswald, S, Meyer zu Schwabedissen, H E, Nassif, A, Modess, C, Desta, Z, Ogburn, E T, Mostertz, J, Keiser, M, Jia, J, Hubeny, A, Ulrich, A, Runge, D, Marinova, M, Lütjohann, D, Kroemer, H K, Siegmund, W

    Published in Clinical pharmacology and therapeutics (01-03-2012)
    “…Hypercholesterolemia frequently occurs in patients treated with efavirenz who cannot be treated adequately with statins because of drug interactions. These…”
    Get full text
    Journal Article